Pharmaceuticals, Biotechnology and Life Sciences
OXFORD, United Kingdom, April 29, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in…
RAPIDe-1 clinical trial enrolling, evaluating PHVS416 as an oral on-demand therapy for HAEOpen IND for the prophylactic evaluation of PHVS416Strong…
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Jack Burnett, President and a director of Ramm Pharma Corp. (“Ramm” or, the…
Fifth Treatment Arm to Evaluate Safety of ELX-02 in Combination with Kalydeco (ivacaftor) Reaffirmed Data Readout for First Four Treatment…
THE WOODLANDS, Texas, April 29, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its first quarter 2021…
WATERTOWN, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated…
EXTON, Pa., April 29, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its…
Conference Call and Webcast Scheduled for Thursday, May 6 at 4:30 p.m. Eastern TimeMALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE)…
MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results…
DUBLIN, Ireland, April 29, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization…